Global Vaccines: A Shot Of Growth For GSK And Pfizer?
Executive Summary
Recent M&A activity in the vaccine industry has narrowed the pool of players. For companies that remain, the opportunity to reshape their positions in the global market comes with an even greater responsibility to contribute meaningfully to continued advances in global public health.